Learn more

ACINO PHARMA AG

Overview
  • Total Patents
    53
  • GoodIP Patent Rank
    187,861
About

ACINO PHARMA AG has a total of 53 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are NEWMARKET PHARMACEUTICALS LLC, Shenzhen zhijun pharmaceutical co ltd and HAINAN HALEE PHARMACEUTICAL CO LTD.

Patent filings per year

Chart showing ACINO PHARMA AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zingraff Marc 12
#2 Scheer Mathias 9
#3 Neuer Klaus 8
#4 Fischer Marc 8
#5 Rey Helene 8
#6 Reher Markus 8
#7 Gillessen Dieter 7
#8 Jager Jurgen 4
#9 Stutz Alfred 3
#10 Cwik Monika 3

Latest patents

Publication Filing date Title
AU2016101552A4 Reduction of the deallylation of naloxone during the storage of a naloxone-containing retard formulation
CH711429A2 A packaged pharmaceutical composition comprising a sustained release formulation of naloxone or a pharmaceutically acceptable salt thereof and a package.
DE102013013064A1 Testing and cleaning device for spray nozzles
DE102012007671A1 High active ingredient pellets
DE102011115690A1 Quetiapine-containing formulations
US2011201633A1 Alfuzosin tablets and synthesis
EP2446882A1 Medicament with improved storage stability containing the active ingredient hydromorphone
DE102010033527A1 Quetiapine tablets
AU2008354622A1 Aqueous pharmaceutical formulation
RS51313B Retard tablets with hydromorphon
MX2009002356A Pharmaceutical formulations comprising clopidogrel.
EP1803716A1 A process for preparation of racemic nebivolol
EP1847258A1 Partial glycerides as lubricants in pharmaceutical compositions comprising thieno[3,2-c]pyridine derivatives
US2007149612A1 Process for preparation of racemic Nebivolol
EP1438961A1 Bioequivalent composition of itraconazole dispersed in a hydrophilic polymer
EP1438960A1 Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability